• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Virtual details big joke

anonymous

Guest
Who REALLY thinks we can detail 5 HCPs per day? They have reps from every company calling and are getting pissed!

Home office is on crack! Go ahead and try to do that, and oh yeah use Challenger!!

What happened to we wont hold you to metrics and that some territories wont be able to hold virtual lunches/details?? Now its metrics, metrics, metrics. We were lied to!
 








Who REALLY thinks we can detail 5 HCPs per day? They have reps from every company calling and are getting pissed!

Home office is on crack! Go ahead and try to do that, and oh yeah use Challenger!!

What happened to we wont hold you to metrics and that some territories wont be able to hold virtual lunches/details?? Now its metrics, metrics, metrics. We were lied to!

What division are you in? Derm isn't having metrics pushed down on us.